Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2024-09-04 Director's Dealing
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Comunicato Internal Dealing
Director's Dealing Classification · 100% confidence The document is titled 'Comunicato Internal Dealing' (Internal Dealing Communication) and uses the template 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This explicitly concerns transactions (trades) made by company directors or senior management (insiders). This directly corresponds to the definition of Director's Dealing. Filing Code: DIRS.
2024-09-04 Italian
Pubblicazione del rendiconto sintetico delle votazioni
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement from Diasorin S.p.A. dated September 4, 2024. The subject ('Oggetto') is 'Pubblicazione del rendiconto sintetico delle votazioni' (Publication of the summary report of the voting results). The text explicitly states that the 'rendiconto sintetico delle votazioni relativo all'Assemblea degli Azionisti' (summary report of the voting results related to the Shareholders' Meeting) has been made available to the public. Since this document is an announcement stating that the voting results report is published and available elsewhere (attached or on the website), it fits the criteria for a Report Publication Announcement (RPA) based on the 'MENU VS MEAL' rule, as it is short (3989 chars) and announces the availability of the actual report. If the document contained the full voting results, it would be classified as DVA (Declaration of Voting Results & Voting Rights Announcements). However, because it is merely the *publication notice* of that report, RPA is the most appropriate classification for the announcement itself.
2024-09-04 Italian
Shareholders' Meeting September 4, 2024 - Summary report on votes
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly details the 'Summary account of the votes on the items of agenda' for a meeting, presenting detailed tables showing votes 'In Favour', 'Against', and 'Abstain' for various agenda items (Item 1, Item 1.1, Item 1.2). This content is characteristic of reporting the official results of a shareholder vote following a general meeting. The definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA) perfectly matches this content, which is distinct from the AGM presentation materials (AGM-R) or the proxy solicitation materials (PSI).
2024-09-04 English
Assemblea degli Azionisti del 4 settembre 2024 - Rendiconto sintetico delle votazioni
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document title explicitly states 'DIASORIN S.p.A. Assemblea ordinaria e straordinaria 4 settembre 2024' (Ordinary and Extraordinary General Meeting) and presents a 'Rendiconto sintetico delle votazioni sui punti all'ordine del giorno' (Summary report of the votes on the agenda items). This content details the voting results for resolutions passed during a General Meeting, which directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). It is not a general AGM presentation (AGM-R) but the official results summary.
2024-09-04 Italian
Diasorin S.p.A. - Shareholders' Meeting September 4, 2024
AGM Information Classification · 99% confidence The document is an official communication from Diasorin S.p.A. dated September 4, 2024, detailing the resolutions passed during its Shareholders' Meeting held on the same day. Key outcomes include the appointment of a statutory auditor and amendments to the company bylaws. This type of announcement, which reports the results and decisions made at a general meeting of shareholders, aligns directly with the definition of AGM Information (AGM-R). Although it mentions the appointment of an auditor (which could relate to AR), the primary focus and context are the meeting outcomes themselves. It is not a full 10-K, an earnings release, or a proxy statement, but a summary of the meeting's decisions.
2024-09-04 English
Diasorin S.p.A. - Assemblea degli Azionisti 4 settembre 2024
AGM Information Classification · 99% confidence The document is a formal announcement dated September 4, 2024, regarding the results of the Shareholders' Meeting ('Assemblea degli Azionisti') of Diasorin S.p.A. It details resolutions passed in both ordinary and extraordinary sessions, such as appointing the auditor (Ernst & Young S.p.A.) and approving amendments to the company bylaws (Statuto Sociale). Key phrases like 'Assemblea degli Azionisti', 'delibere assembleari assunte', and the context of voting results strongly point towards a filing related to shareholder meetings and their outcomes. Reviewing the definitions: - 10-K/IR: Not a full annual or interim financial report. - ER/MDA: Not an earnings release or management discussion. - IP/FS: Not a general investor presentation or factsheet. - DEF 14A: Not specifically about remuneration. - The document explicitly reports the results of the shareholder vote/meeting decisions. This fits best under 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it summarizes the decisions made by the shareholders during the meeting, which is the primary purpose of the communication, even though it also touches upon governance changes (which might otherwise suggest CGR or DEF 14A, but the context is the meeting outcome itself). Alternatively, since it is a formal announcement of meeting outcomes, it could be considered a Regulatory Filing (RNS) or potentially related to Governance Information (CGR) due to bylaw changes. However, DVA is the most specific category for reporting the results of a general meeting.
2024-09-04 Italian

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.